Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-29

FDA Approved: LAMOTRIGINE — Supplemental Application (Advagen Pharma Limited)

View source ↗

Summary

The FDA approved Advagen Pharma Limited's supplemental application for lamotrigine (generic lamotrigine). This is a supplemental approval for their generic lamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (generic) (Lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)